Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketorolac in Palatoplasty
Sponsor: The University of Texas Health Science Center, Houston
Summary
The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively
Official title: Ketorolac in Palatoplasty: A Randomized Blinded Controlled Trial.
Key Details
Gender
All
Age Range
6 Months - Any
Study Type
INTERVENTIONAL
Enrollment
74
Start Date
2021-09-17
Completion Date
2027-04-01
Last Updated
2026-02-19
Healthy Volunteers
No
Conditions
Interventions
Ketorolac
Ketorolac 0.5mg/kg will be administered intra-operatively at the conclusion of the case and 3 more doses scheduled every 8 hours in the first 24 hours post-operatively for a total of 4 doses of Ketorolac
Placebo
0.9% Normal Saline will be administered intra-operatively at the conclusion of the case and 3 more doses scheduled every 8 hours in the first 24 hours post-operatively for a total of 4 doses of normal saline.
Locations (1)
The University of Texas Health Science Center at Houston
Houston, Texas, United States